This was the stock's second consecutive day of gains.

Fevertree Drinks' recent strategic partnership with Molson Coors is set to accelerate its growth in the U.S. See why FQVTF ...

Molson Coors (TAP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Fintel reports that on February 5, 2025, Citigroup upgraded their outlook for Molson Coors Beverage (NYSE:TAP) from Sell to ...

Molson Coors Beverage (NYSE:TAP – Get Free Report) has been assigned an average rating of “Hold” from the fourteen analysts that are presently covering the stock, MarketBeat reports. One equities ...

Greenleaf Trust lowered its position in shares of Molson Coors Beverage (NYSE:TAP – Free Report) by 12.9% during the fourth ...

Fever-Tree is already the largest tonic and ginger beer brand in the US by value: but the brand believes there’s still huge ...

Citi upgraded Molson Coors (TAP) to Neutral from Sell with a price target of $57, up from $47. The firm says its fundamental thesis has largely ...

Molson Coors will pay £71m ($88m) for an 8.5% stake in Fever-Tree Drinks Plc: a deal which sent Fever-Tree shares soaring ...

The London-listed mixer-maker said Molson Coors would acquire an 8.5% shareholding in Fevertree.

CHIPPEWA FALLS, Wis. (WEAU) - Dick and Jake Leinenkugel followed up their initial request to discuss the purchase of the ...

Underpinning the partnership and reflecting Molson Coors’ long-term focus on – and belief in – the opportunity, the company has agreed to acquire an 8.5% stake in Fevertree Drinks plc, resulting in ...